| Display title | Chemistry:ZM-241,385 |
| Default sort key | ZM-241,385 |
| Page length (in bytes) | 3,527 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 817260 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Ohm |
| Date of page creation | 11:55, 22 April 2023 |
| Latest editor | imported>Ohm |
| Date of latest edit | 11:55, 22 April 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | ZM-241,385 is a high affinity antagonist ligand selective for the adenosine A2A receptor.
In animal models, ZM-241,385 has been shown to protect against beta amyloid neurotoxicity and therefore may be useful as a treatment for Alzheimer's disease. ZM-241,385 has also been shown to enhance L-DOPA derived... |
